Search
Patexia Research
Case number IPR2017-01115

Pfizer, Inc. v. Genentech, Inc. et al. > Documents

Date Field Doc. No.PartyDescription
Mar 24, 2017 1046 Klareskog, double-blind randomised controlled trial Download
Mar 24, 2017 1035 Letter from the Medicines Control Agency to Edwards Download
Mar 24, 2017 1012 T. Pincus & C.M. Stein, No Evidence of disease in rheumatoid arthritis Download
Mar 24, 2017 1049 Decision of the European Patent Office re-EP1179681 Download
Mar 24, 2017 1040 Moreland Etanercept Therapy in Rheumatoid Arthritis Download
Mar 24, 2017 3 MOTION FOR JOINDER Download
Mar 24, 2017 1003 Elena Massarotti CV Download
Mar 24, 2017 1007 Saleh letter to Comprehensive Cancer Center, dated October 1, 1998 Download
Mar 24, 2017 1053 Drugs@FDA, FDA Applciation No. (BLA) 103705 Download
Mar 24, 2017 1006 Gryn letter to Parker, dated May 6, 1998 Download
Mar 24, 2017 1057 ODell, Treatment of Rheumatoid Arthritis with Methotrexate Alone Download
Mar 24, 2017 1026 Maloney IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy (1997) Download
Mar 24, 2017 1038 Kremer (1995) Download
Mar 24, 2017 1013 William Schwieterman FDA Conversation Download
Mar 24, 2017 1044 Wendler, Rituximab in Practice Download
Mar 24, 2017 1054 1997 Form 10-K405.A filed by IDEC Pharmaceuticals Download
Mar 24, 2017 1019 Kremer, Combination Therapy with Biologic Agents in Rheumatoid Arthritis Download
Mar 24, 2017 1039 Declaration by Jonathan Charles Wright Edwards Download
Mar 24, 2017 1024 IPR2015-00415 Patent Owner's Preliminary Response Download
Mar 24, 2017 1048 Gabriel, the Epidemiology of Rheumatoid Arthritis Download
Mar 24, 2017 1029 Maloney et al., IDEC-C2B8 (1997) Download
Mar 24, 2017 1018 Felson American College of Rheumatology Download
Mar 24, 2017 1025 Maloney Phase 1 Clinical Trial Using Escalating Single-Dose Infusion (1994) Download
Mar 24, 2017 1052 FDA, Rituxan Approval Letter, 97-0244 (November 26, 1997) Download
Mar 24, 2017 1 Pfizer, Inc.s Power of Attorney Download
Mar 24, 2017 1055 Internet Archive Capture of Genentech Website for Rituxan Download
Mar 24, 2017 1036 Information for patients undergoing treatment of rheumatoid arthritis Download
Mar 24, 2017 1020 Guidance for Industry Clinical Development Programs for Drugs Download
Mar 24, 2017 1017 Boers, World Health Organization Download
Mar 24, 2017 1041 Remicade Label 1998 Download
Mar 24, 2017 1037 Rituxan label 1997 Download
Mar 24, 2017 1023 First Declaration of Ronald F. van Vollenhoven, dated July 30, 2007 Download
Mar 24, 2017 1021 Weinblatt et al., New England Journal of Medicine Download
Mar 24, 2017 1016 Boers et al., The Lancet, 350.309-18 (1997) Download
Mar 24, 2017 1002 Declaration of Elena Massarotti MD Download
Mar 24, 2017 1001 U.S. Patent 7,820,161 Download
Mar 24, 2017 1027 WO 95.03770 Download
Mar 24, 2017 1008 Latov letter to Horvath, dated November 16, 1998 Download
Mar 24, 2017 1011 American Colelge of Rheumatology Subcommittee Download
Mar 24, 2017 1047 Bathon, Comparison of Etanercept and Methotrexate (2000) Download
Mar 24, 2017 1005 Eisenberg letter to Genetech Oncology & IDEC Download
Mar 24, 2017 1030 Edwards, The Predictable Effect of Small Immune Complexes Download
Mar 24, 2017 1045 Edwards, Efficacy of B-Cell-Targeted Therapy (2004) Download
Mar 24, 2017 1031 Edwards, The case for Killing Cells with ANTI-CD20 in RA Download
Mar 24, 2017 2 PETITION FOR INTER PARTES REVIEW Download
Mar 24, 2017 1009 Pestronk letter to Department of Neurology, dated October 12, 1998 Download
Mar 24, 2017 1010 Looney letter to Duthcer dated January 15, 1999 Download
Mar 24, 2017 1043 Buch, Updated consensus statemetn on the use of rituximab Download
Mar 24, 2017 1033 The University College London Hospitals, October 30, 1998 Letter Download
Mar 24, 2017 1022 Maini et al., Arthritis & Rheumatism Download
Mar 24, 2017 1042 FDA, 64 Fed. Reg. 7898 Download
Mar 24, 2017 1004 Second Declaration of Ronald F. van Vollenhoven, dated January 19, 2010 Download
Mar 24, 2017 1014 Kremer, Methotrexate for Rheumatoid Arthritis Download
Mar 24, 2017 1034 The Joint UCL,UCLH Committees on the Ethics of Human Research Download
Mar 24, 2017 1051 Kalden, Rescue of DMARD Failure by Means of Monoclonal Antibodies Download
Mar 24, 2017 1015 ODell, Methotrexate Use (1997) Download
Mar 24, 2017 1056 Declaration from Internet Archive Download
Apr 6, 2017 4 Notice of Defective Petition Download
Apr 7, 2017 1046 Klareskog, Double-Blind Randomised Controlled Trial Download
Apr 7, 2017 1046 Klareskog, Double-Blind Randomised Controlled Trial Download
Apr 11, 2017 5 Notice of Accepting Corrected Petition Download
Apr 14, 2017 6 Power of Attorney Download
Apr 14, 2017 7 Mandatory Notice Download
May 5, 2017 8 Notice of Deposition of Elena Massarotti Download
May 9, 2017 10 Petitioner's Updated Exhibit List (05 09 2017) Download
May 9, 2017 1058 Ex. 1058 - Declaration of Charles B. Klein ISO PHV Motion Download
May 9, 2017 9 Petitioner's Unopposed Motion For Pro Hac Vice Admission Of Charles B. Klein And Eimeric Reig-Plessis Download
May 9, 2017 1059 Ex. 1059 - Declaration of Eimeric Reig-Plessis ISO PHV Motion Download
Jul 10, 2017 11 Joint Motion to Dismiss Download
Jul 18, 2017 13 Decision Institution of Inter Partes Review, Grant of Motion for Joinder, and Grant of Joint Motion to Dismiss Certain Challenges in the Petition Download
Jul 18, 2017 12 Granting Motion for Pro Hac Vice Recognition of Mr. Charles B. Klein and Mr. Eimeric Reig-Plessis 37 C.F.R. sec 42.10(c) Download
Feb 22, 2018 14 IPR2016-01614 Final Written Decision Download
Menu